High expression of APC is an unfavorable prognostic biomarker in T4 gastric cancer patients

doi:10.3748/wjg.v25.i31.4452

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 31

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6768)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

547

WORD

338

HTML

3212

Figures (1-6)

246

Tables (1-3)

194

Sum=4537

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

768

Download

1463

Sum=2231

Aug 21, 2019 (publication date) through Jul 23, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Aug 21, 2019; 25(31): 4452-4467
Published online Aug 21, 2019. doi: 10.3748/wjg.v25.i31.4452

Full Size Figure Download Figure

Figure 4 Genome-wide analysis of miRNAs associated with APC^high. A: Relationship between the correlation coefficient and correlation P-value; B: MiRNAs that were significantly positively correlated (red), negatively correlated (green), and had no correlation (blue) with APC^high, as well as the heatmap of miRNAs associated with APC^high; C: mRNA-miRNA regulatory network. APC: Adenoma polyposis coli.

Citation: Du WB, Lin CH, Chen WB. High expression of APC is an unfavorable prognostic biomarker in T4 gastric cancer patients. World J Gastroenterol 2019; 25(31): 4452-4467
URL: https://www.wjgnet.com/1007-9327/full/v25/i31/4452.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i31.4452